Mercia Asset Management Share Discussion Threads

[riverman77] 24/6/2021 15:48

This is now looking extremely interesting. It feel like it has reached an inflexion point where the asset management side has become solidly profitable while the balance sheet is seeing realisations come through thick and fast (and at big uplifts). The Singer note estimates the balance sheet investments themselves worth 40p, while the asset management side worth 10p on conservative measures. However, could see significant upside from this if we see further realisations.

[columbarius] 24/6/2021 08:48

Broker update from N+1 Singer. Their sum of the parts valuation rises to c.50p/share. Importantly, their figure does not capture value embedded in investments. That remains hidden until the investments are realized (the main reason I invested here).

[turbocharge] 23/6/2021 16:21

Topped up today!

[turbocharge] 23/6/2021 16:20

Today's news seems to have ignited the share price due north....

[gb904150] 23/6/2021 15:59

Well, that was a nice update. I thought it was a strange time to release it at 3:16pm but I see that NTV and NTN northern trusts announced their annual reports at 3pm...so fair enough!

[robsy2] 18/5/2021 12:29

Good points. MHC seems to be doing alright.

[columbarius] 18/5/2021 11:44

One step at a time. I don’t think their 30.7m share of the Oxgene sale was tuppence ha’penny and it helped to establish the uptrend when the company was being shunned. NAC was sold during covid hype so I’ve no problem with that one either. Portfolio companies can IPO without Mercia selling their holding eg. MHC.

[varies] 18/5/2021 11:44

we hear very little about nDreams which is, I believe, MERC's most valuable holding.
An IPO or sale of nDreams at an enhanced price would certainly boost MERC's asset value

[robsy2] 18/5/2021 10:37

Heh heh! I think successful exits are well considered by private equity investors though if you can keep good investments why sell?HGT, in which i am invested,doesn’;t sell many and they are very successful.
With the business model merc have there is less pressure to sell out so i would rather they kept hold of the winners as long as possible.

[redartbmud] 18/5/2021 10:25

Maybe the business is maturing, but why do I always feel cheated when they sell holdings that only seem to realise tuppence ha'ppeney in old money.
Shouting the roof off when letting off a penny banger isn't the same as a broadside from a dozen or more 16" guns.

[columbarius] 18/5/2021 10:16

The article referenced by this Faradion tweet says the company is working on an IPO. Should be interesting.

[p1nkfish] 17/5/2021 10:46

Certainly the picture is better now than at any other time.

[columbarius] 17/5/2021 10:36

Well done for manning up and making money. I can’t imagine ST doing the same.
We’ve been tipped off that they’re currently working on another exit. I’m expecting news in the not too distant future.

[p1nkfish] 17/5/2021 09:53

It may be ST's achilles heel. I was also extremeley annoyed with the way they arranged the funding but when the price is low enough, park the emotion & buy. Can't say I would always do that but in this case there was money to be made so came off my hobby-horse and added to holding.

[robsy2] 17/5/2021 09:48

Thanks columbariosfor sharing. Mercia has so many irons in the fire and a fund management business to deal with the day to day cost + network of opportunity that its just a question of patience.ST would be all over this if he hadn’t got sniffy.

[columbarius] 17/5/2021 08:40

Another obvious winner for MERC.

[columbarius] 12/5/2021 11:52

This job advert gives some hints on the progress Voxpopme is making. It’s encouraging to see a small British company expanding in the US. As retail gets more remote from the customer I think they’re in a good space. Another exciting Mercia portfolio company.

[columbarius] 29/4/2021 12:10

Lateral flow tests companies are overbought. LFTs are a cheap and cheerful alternative for third world countries reliant on charity and are of interest to the UK government as they’re leading us into their ranks. Sense is producing rapid PCR type covid tests and will disrupt the lateral flow market. Mercia made money for their investors out of ABDX by achieving an excellent exit via IPO at the height of the hype. DYOR.

[p1nkfish] 29/4/2021 09:12

Abingdon Health from 27/04/21.

1) Lateral flow testing market is forecast to be worth $10.2bn by 2025
2) Abingdon remains well-positioned to be the 'go-to' provider for high quality rapid tests."

"The Company is continuing its manufacturing expansion, after the successful completion of the first phase, in order to meet market demand for lateral flow testing. This expansion is not only for the AbC-19™ rapid test, but also for the expected demand from our contract service partners, both for COVID-19 and non-COVID assays. The lateral flow testing market is forecast to be worth $10.2bn by 2025, and Abingdon remains well-positioned to be the 'go-to' provider for high quality rapid tests."

[columbarius] 28/4/2021 20:46

Launch of game changing rapid covid test getting closer.

[tomps2] 23/4/2021 10:08

MERC virtual investor event, held on the 20/04/21

This showcases Mercia’s team, portfolio companies and an overview of the Group’s recent performance. Led by Mercia’s CEO Dr Mark Payton, this provides insight on the progress that Mercia is making on its three-year strategy. Mark was joined by Martin Glanfield, CFO, Julian Viggars, CIO and Jill Williams, Investment Director. The event includes short presentations from the CEOs of several Mercia investee companies within both its direct investment portfolio and third-party manage funds’ portfolios. At the end there is a short Q&A.

Watch the event here:

Or listen to the podcast version here:

[p1nkfish] 22/4/2021 15:24

download as PDF and zoom in.

[varies] 22/4/2021 15:09

TurboCharge
Thank you for posting the "slick publication". I only wish that my eyesight was better as I have great difficulty reading it !

[turbocharge] 22/4/2021 14:57

Very slick publication